Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan C K Tovey

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Progress in Retinal and Eye Research|October 5, 2011
Gene therapy in the cornea: 2005--presentRajiv R Mohan, Jonathan C K Tovey, Ajay Sharma, et al.
Experimental Eye Research|July 6, 2010
AAV serotype influences gene transfer in corneal stroma in vivoAjay Sharma, Jonathan C K Tovey, Arkasubhra Ghosh, et al.
Investigative Ophthalmology & Visual Science|May 10, 2011
Significant inhibition of corneal scarring in vivo with tissue-selective, targeted AAV5 decorin gene therapyRajiv R Mohan, Ashish Tandon, Ajay Sharma, et al.
Plos One|May 3, 2011
Efficacious and safe tissue-selective controlled gene therapy approaches for the corneaRajiv R Mohan, Sunilima Sinha, Ashish Tandon, et al.
Plos One|November 1, 2011
Targeted decorin gene therapy delivered with adeno-associated virus effectively retards corneal neovascularization in vivoRajiv R Mohan, Jonathan C K Tovey, Ajay Sharma, et al.
Journal of Refractive Surgery (Thorofare, N.J. : 1995)|March 6, 2012
Vorinostat: a potent agent to prevent and treat laser-induced corneal hazeAshish Tandon, Jonathan C K Tovey, Michael R Waggoner, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|January 29, 2011
Polyethylenimine-conjugated gold nanoparticles: Gene transfer potential and low toxicity in the corneaAjay Sharma, Ashish Tandon, Jonathan C K Tovey, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Progress in Retinal and Eye Research|October 5, 2011
Gene therapy in the cornea: 2005--presentRajiv R Mohan, Jonathan C K Tovey, Ajay Sharma, et al.
Experimental Eye Research|July 6, 2010
AAV serotype influences gene transfer in corneal stroma in vivoAjay Sharma, Jonathan C K Tovey, Arkasubhra Ghosh, et al.
Investigative Ophthalmology & Visual Science|May 10, 2011
Significant inhibition of corneal scarring in vivo with tissue-selective, targeted AAV5 decorin gene therapyRajiv R Mohan, Ashish Tandon, Ajay Sharma, et al.
Plos One|May 3, 2011
Efficacious and safe tissue-selective controlled gene therapy approaches for the corneaRajiv R Mohan, Sunilima Sinha, Ashish Tandon, et al.
Plos One|November 1, 2011
Targeted decorin gene therapy delivered with adeno-associated virus effectively retards corneal neovascularization in vivoRajiv R Mohan, Jonathan C K Tovey, Ajay Sharma, et al.
Journal of Refractive Surgery (Thorofare, N.J. : 1995)|March 6, 2012
Vorinostat: a potent agent to prevent and treat laser-induced corneal hazeAshish Tandon, Jonathan C K Tovey, Michael R Waggoner, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|January 29, 2011
Polyethylenimine-conjugated gold nanoparticles: Gene transfer potential and low toxicity in the corneaAjay Sharma, Ashish Tandon, Jonathan C K Tovey, et al.
Pageof 1